American Academy Of Clinical Toxicology 2024
BioSpyder is thrilled to announce our participation in the upcoming American Academy of Clinical Toxicology (NAACT) conference, taking place from September 19-23, 2024 in Denver, CO.
Please visit our website for details.
BioSpyder is thrilled to be attending the upcoming Japanese Society of Toxicology meeting for the first time (July 3rd-July 5th 2024). Please stop by our booth 88 3F. We’d be happy to discuss enabling high throughput toxicology!
BioSpyder eagerly awaits its participation in the upcoming Society of Toxicologic Pathology (SOT) in Baltimore, Maryland, from June 16th to June 19th, 2024. We look forward to talking extraction-free RNA sequencing with you! 👋 #SOTAnnualMeeting #Toxicology #Biospyder #pathology
BioSpyder, a leader in molecular biology assays, introduces TempO-LINC, a proprietary high-throughput single-cell genomics platform. Full article link :biospyder.com/news/biospyder…
🩸 Exciting News! BioSpyder is thrilled to announce our presence at the American Society of Hematology (ASH) conference this weekend, Dec 9-12, at the San Diego Convention Center! 🌟 Join us in advancing hematology research with our new Dried Blood Spot assay.#ASH #ASHconference
🔬 Exciting News! We're thrilled to announce our participation at the Society for Immunotherapy of Cancer Conference, Nov 3-5 in San Diego! Join us in advancing cancer immunotherapy through innovative research and collaboration! #SITC #SITCconference #Immunotherapy
BioSpyder has been awarded a NIH Grant to fund research on Alzeheimer’s Disease. The award was granted to perform Alzheimers research using blood samples with BioSpyder’s new Dried Blood Spot (DBS) Assay.
#Alzheimer #researchanddevelopment #biospyder #research
BioSpyder is launching TempO-LINC: Fixed Single-cell Gene Expression Profiling. Reduce the cost of your single-cell studies by over 50%.
BioSpyder launched TempO-SPan for COVID-19 testing. The test is being offered by @BioClavis to the U.K. market - high throughput, cost-effective molecular testing.businesswire.com/news/home/2…
#Covid19UK #covidtest
BIOSPYDER FILES ACTION AGAINST HTG MOLECULAR DIAGNOSTICS businesswire.com/news/home/2… $HTGM - Puts HTG on notice that we will vigorously defend our premier technology and intellectual property!
BioSpyder's TempO-Seq holds promise as a solution for this bottleneck #SARSCOV2 #geneexpression theatlantic.com/science/arch…
Over the past 5-years, we've grown this contract from $5 to $25 Million. Thanks to the @EPAresearch for their support! This contract helps establish BioSpyder as a leader in genetic toxicology screening.
#geneexpression #toxicology
newswire.com/news/biospyder-…
BioSpyder's new website launched! Did you know you can find tons of information about @Temposeq and #geneexpression #transcriptomics on it? Check it out!
biospyder.com
BioSpyder retweeted
Did you know @TempOseq has assays covering the biological universe, ranging from DNA - RNA (including miRNAs/ncRNAs) to single cells?
Find out more:
view.genial.ly/5e34091235ef4… (and biospyder.com).
BioSpyder retweeted
Replying to @ToxStrategies
@ToxStrategies @ebtoxc @EFSA_EU @EPA informational session at #SOT2018 shared experiences of using systematic review in risk assessment
BioSpyder retweeted
We are pleased to announce a new practice area focused on the transition in toxicological science to #invitro and #computational #toxicology. To do this, two leading experts in the field have joined our team: Drs. Miyoung Yoon and Rebecca Clewell. toxstrategies.com/2018/03/dr…
BioSpyder retweeted
We are excited to be presenting and exhibiting at the #SOT2018 in San Antonio, TX next week. Click the link to see what we'll be presenting, and stop by our booth (#1659) to catch up! gallery.mailchimp.com/137d75…
BioSpyder retweeted
Safe travels to all those headed to #2018SOT over the next few days. Can’t wait to see you in San Antonio!
















